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Abstract. 
 
Chicken acidic leucine-rich EGF-like do-
main containing brain protein (CALEB) was identified 
by combining binding assays with immunological 
screens in the chicken nervous system as a novel mem-
ber of the EGF family of differentiation factors. cDNA 
cloning indicates that CALEB is a multidomain protein 
that consists of an NH
 
2
 
-terminal glycosylation region, a 
leucine-proline–rich segment, an acidic box, a single 
EGF-like domain, a transmembrane, and a short cyto-
plasmic stretch. In the developing nervous system, 
CALEB is associated with glial and neuronal surfaces. 
CALEB is composed of a 140/130-kD doublet, an 80-kD 
band, and a chondroitinsulfate-containing 200-kD com-
ponent. The latter two components are expressed in the 
embryonic nervous system and are downregulated in 
the adult nervous system. CALEB binds to the extra-
cellular matrix glycoproteins tenascin-C and -R. In 
vitro antibody perturbation experiments reveal a par-
ticipation of CALEB in neurite formation in a permis-
sive environment.
 
T
 
he
 
 differentiation of the nervous system is the re-
sult of a complex series of cell communications me-
diated by molecules shown to participate in differ-
ent aspects of development such as mitogenic signaling,
differentiation of precursor cells into neurons and glial cells,
outgrowth and pathfinding of axons, and the establish-
ment of synaptic connections. One form of cell communi-
cation involves the release of molecules termed trophic or
tropic factors. One class of proteins that are released and
display mitogenic and differentiation-inducing properties
in the nervous system is the neuregulins (Ben-Baruch and
Yarden, 1994; Carraway and Burden, 1995). They belong
to a family of membrane-bound growth and differentia-
tion factors that are characterized by an EGF-like domain
with a specific cysteine spacing and other invariant amino
acids in specific positions. Two well-known members of this
protein family are EGF and TGF-
 
a
 
. The neuregulins bind
to and activate the receptor tyrosine kinase ErbB3/4 by in-
ducing tyrosine phosphorylation (Carraway and Cantley,
1994), for which the EGF-like domain appears to be nec-
essary and sufficient. Alternative pre-mRNA splicing gene-
rates a dozen of related proteins that are expressed in a va-
riety of mesenchymal and neuronal tissues (Meyer and
Birchmeier, 1994), and some isoforms of neuregulin con-
tain an Ig-like domain (Peles and Yarden, 1993). Although
the specific function of this Ig-like domain is currently un-
known, gene targeting experiments have shown it to be es-
sential for developmental processes (Kramer et al., 1996),
and studies with mutant forms reveal that it might be re-
quired to allow cleavage products of the neuregulins to in-
teract with the extracellular matrix (Loeb and Fischbach,
1995). In general, Ig-modules are thought to mediate pro-
tein–protein interactions (Brümmendorf and Rathjen,
1995).
Another family of proteins composed of Ig-like and, in
several cases, fibronectin type III–like domains is made up
of the axonal members of the immunoglobulin superfam-
ily (IgSF)
 
1
 
 that participate in contact-dependent commu-
nications between neural cells during development. These
axon-associated IgSF members are implicated in different
aspects of neurohistogenesis, e.g., in radial and tangential
migration of neuronal precursor cells, in neurite fascicula-
tion, in contact-dependent axonal guidance, as well as in
contact-dependent inhibition of axonal growth (Brümmen-
dorf and Rathjen, 1995; Cunningham, 1995). Most of these
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Abbreviations used in this paper
 
: aa, amino acid; CALEB, chicken
acidic leucine-rich EGF-like domain containing brain protein; E, embry-
onic day; ECM, extracellular matrix; IgSF, immunoglobulin superfamily;
IPL and OPL, inner and outer plexiform layer; NCAM, neural cell adhe-
sion molecule; NgCAM, neuron-glia cell adhesion molecule; NrCAM, N
gCAM-related cell adhesion molecule; OFL, optic fiber layer; TN-C and -R,
tenascin-C and -R.
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axon-associated Ig-like glycoproteins are typical multido-
main proteins consisting of a number of different and, in
most cases, repeated structural and functional units. An
important feature of these proteins is their binding to sev-
eral distinct proteins (Brümmendorf and Rathjen, 1996).
For example, the F11 protein is one such multifunctional
protein that interacts with at least two IgSF members of
the L1 subgroup (NgCAM-related cell adhesion molecule
[NrCAM] and neuron–glia cell adhesion molecule [Ng-
CAM]), with two extracellular matrix glycoproteins (tena-
scin-R [TN-R] and tenascin-C [TN-C]), and with the
receptor tyrosine phophatase 
 
b
 
/
 
z
 
 (Rathjen et al., 1991;
Zisch et al., 1992; Brümmendorf et al., 1993; Morales et al.,
1993; Pesheva et al., 1993; Peles et al., 1995; Brümmendorf
and Rathjen, 1996). In particular, the axon-associated ex-
tracellular matrix (ECM) glycoproteins of the developing
nervous system consist of a plethora of different struc-
tural  domains and undergo multiple interactions with
other proteins. For example, the tenascin family members
are composed of a cysteine-rich region, several EGF- and
fibronectin type III–like modules, and a fibrinogen-like
domain (Chiquet-Ehrismann et al., 1995; Nörenberg et al.,
1995).
The multitude of binding activities and the multidomain
structure of many of these axon-associated members of
the IgSF and the ECM glycoproteins suggested to us that
other interactions with so far uncharacterized components
might occur during nervous system development. The rel-
atively broad binding specificity of many axon-associated
proteins might be used to identify novel cell surface or ex-
tracellular matrix proteins implicated in the differentiation
of the nervous system. We have therefore combined the
binding properties of these components with immunologi-
cal screens to characterize proteins in the chick nervous
system.
In this report we describe molecular, cellular, and func-
tional properties of a novel protein of the developing chick
nervous system that was identified by its interaction with
the ECM glycoproteins TN-R and TN-C. This protein,
termed chicken acidic leucine-rich EGF-like domain con-
taining brain protein (CALEB), is a transmembrane gly-
coprotein that contains an EGF-like domain close to the
plasma membrane–spanning domain. The EGF-like domain
resembles those found in other proteins such as EGF it-
self, neuregulin, or TGF-
 
a
 
 and might therefore function as
a receptor recognition site. Histological investigations dem-
onstrate that CALEB is restricted to the developing and
adult nervous system and is associated with neuronal and
glial surfaces. Binding studies support the interaction be-
tween CALEB and TN-R and between CALEB and TN-C.
In vitro antibody perturbation experiments indicate that
CALEB is implicated in neurite formation in a permissive
environment provided by F11, NgCAM, laminin, or vitro-
nectin.
 
Materials and Methods
 
Generation and Screening of mAbs to Binding Proteins
 
Immunizations and the generation of hybridomas secreting mAbs to
axon-associated glycoprotein fractions by fusions of splenocytes with my-
eloma cell line P3X63-Ag8.653 were performed as described previously
(Rathjen et al., 1987
 
a
 
,
 
b
 
). Selected mAbs that do not recognize known
axon-associated proteins were further tested for whether they recognize
an antigen that binds to F11, neural cell adhesion molecule (NCAM), Ng-
CAM, NrCAM, laminin, TN-C, or TN-R. For this purpose these proteins
were immobilized on ELISA plates (200 ng per well in 150 
 
m
 
l PBS) fol-
lowed by blocking of the plates with BSA (1% in PBS supplemented with
0.5% Tween 20). Plates were then incubated overnight at 4
 
8
 
C with deter-
gent extracts (1% Triton X-100 in PBS added with protease inhibitors) of
embryonic day (E) 16 retinas (200 
 
m
 
l per well at a protein concentration of
13.8 mg/ml) followed by four washing steps. ELISA plates were then incu-
bated with preselected (see above) hybridoma supernatants (150 
 
m
 
l per
well) or with purified mAbs at a concentration of 1 
 
m
 
g/ml for 2 h at room
temperature. Binding of antibodies was visualized with peroxidase-conju-
gated secondary antibodies and the o-phenylenediamine reaction.
 
Antibodies and Purification of NrCAM, NgCAM, F11, 
Neurofascin, 3/11-Antigen, 12/36-Antigen, or CALEB
 
The purification of F11, NgCAM(G4), NrCAM(Bravo), neurofascin, and
NCAM from detergent extracts (1% Triton X-100) of plasma membrane
preparations of adult chicken brain and the specificity of the correspond-
ing monoclonal and polyclonal antibodies and their Fab fragments have
been detailed elsewhere (Rathjen et al., 1987
 
a
 
,
 
b
 
; Wolff et al., 1987; Brüm-
mendorf et al., 1989; de la Rosa et al., 1990; Morales et al., 1993). TN-R or
-C was isolated from urea extracts of adult chicken brains by immunoaf-
finity chromatography as described using mAb 23-13 or mAb M1, respec-
tively (Chiquet and Fambrough, 1984; Rathjen et al., 1991; Nörenberg et al.,
1992). Hybridomas producing mAb M1 directed to TN-C were obtained
from the Developmental Studies Hybridoma Bank (John Hopkins Uni-
versity School of Medicine, Baltimore, MD). CALEB was purified either
from Triton X-100 extracts of embryonic or adult retinas by immunoaffin-
ity chromatography using mAb 4/1 coupled to CNBr-activated Sepharose
(Pharmacia LKB Biotechnology, Inc., Piscataway, NJ). After extensive
washing with solubilization buffer, the affinity column was washed with 3
column volumes 1.2 M NaCl in PBS to elute copurifying TN-C. Bound
CALEB was then eluted from the affinity column by 0.1 M diethylamine,
pH 11.5, followed by neutralization. Polyclonal antibodies to CALEB
were generated in rabbits by subcutaneous injection at multiple sites with
10–15 
 
m
 
g of immunoaffinity-purified CALEB obtained from adult retinas
at 2-wk intervals. The 12/36- or the 3/11-antigen was isolated from deter-
gent extracts of embryonic chicken brains by immunoaffinity chromatog-
raphy using mAb 12/36 or 3/11, respectively. (Hybridomas secreting mAb
12/36 or 3/11 were generated using a screen as outlined for mAb 4/1. Each
antibody recognizes an as-of-yet unknown axon-associated cell surface
protein [our unpublished observations].) Polyclonal rabbit antibodies to
the 3/11- or 12/36-antigen were obtained by using immunoaffinity-purified
material and the same immunization protocol as described above for
CALEB. Fab fragments were produced from the IgG fraction by mercuri-
papain digestion according to Porter (1959).
 
Protein Analytical Procedures
 
Concentrations of protein solutions were determined according to Peter-
son (1977). SDS-PAGE (Laemmli, 1970) was performed with 7% acryl-
amide under reducing conditions followed by silver staining (Ansorge,
1985). Western blots of CALEB components were analyzed using poly-
clonal antibodies or mAb 4/1 to CALEB followed by labeling with alka-
line phosphatase–conjugated secondary antibodies and 5-bromo-4-chloro-
3-indolyl-phosphate/Nitro blue tetrazolium (BCIP/NBT) staining. To
obtain internal CALEB amino acid sequences, peptides were generated
from carboxamidomethylated CALEB 140- or 80-kD polypeptides by di-
gestion with trypsin or Asp-N and separated by reverse-phase, high-pres-
sure liquid chromatography using a trifluoroacetic-acetonitrile buffer sys-
tem. Peptides were subjected to Edman degradation on a gas-phase
sequenator. NH
 
2
 
-terminal sequences of the 140- or 80-kD CALEB com-
ponents were obtained from bands blotted on a Problott membrane (Ap-
plied Biosystems, Inc., Foster City, CA) according to the instructions of
the manufacturer.
 
Cloning, DNA Sequencing, and Transfection
 
An adult chicken eye cDNA library randomly primed and inserted into
 
l
 
gt11 phage vector (Clontech, Palo Alto, CA) was screened by mAb 4/1 
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by standard immunoscreening methods as described by Huynh et al. (1985).
cDNA clone D1, which expressed insert-encoded polypeptide reactive with
mAb 4/1 to CALEB, was isolated and further analyzed (Ausubel et al.,
1994; Sambrook et al., 1989). DNA probes derived from clone D1 were
used to isolate additional CALEB-encoding cDNA clones by hybridiza-
tion using the DIG-technology (Boehringer Mannheim Corp., Indianapolis,
IN). Six independent overlapping cDNA clones (D1–D6) were isolated.
Insert of clone D1 encodes amino acids (aa) 102–440, of D2 aa 302–551, of
D3 aa 1–309, of D4 aa 104–344, of D5 aa 102–387, and of D6 aa 412–551.
cDNA inserts from purified phages were subcloned into the plasmid
Bluescript KS(
 
1
 
) (Stratagene, La Jolla, CA). Nucleotide sequences were de-
termined on both strands by the dideoxy chain termination method of
Sanger et al. (1977) and an automatic fluorescent laser sequencer-DNA se-
quencer (Pharmacia LKB Biotechnology Inc.). Using standard cloning
procedures, the insert of cDNA clone D1 was combined with inserts of
cDNA clones D2 and D3 to generate a continuous CALEB open reading
frame, which was then cloned into the eukaryotic expression vector pSG5
(Stratagene). Transient transfection and analysis of expression by indirect
immunofluorescence using mAb 4/1 were performed with slight modifica-
tions as described elsewhere (Brümmendorf et al., 1993). Nucleotide and
amino acid sequences were analyzed using the HUSAR program package
(German Cancer Research Center, Heidelberg, Germany). Sequence
alignments were performed using the programs clustal and bestfit of
HUSAR.
 
Biosynthetic Labeling and Enzymatic Digestions
 
Biosynthetic labeling of retinal cells in vitro with 200 
 
m
 
Ci/ml [
 
35
 
S]sulfate
(DuPont/New England Nuclear, Wilmington, DE) was performed in cul-
ture medium in which MgSO
 
4
 
 was replaced by MgCl
 
2
 
 (Gibco Laborato-
ries, Grand Island, NY) during the labeling period of 24 h. CALEB immu-
noaffinity isolate from labeled cells was digested with neuraminidase
(Boehringer Mannheim), chondroitinase ABC (Miles, Inc., Kankakee,
IL), heparinase (Sigma Chemical Co., St. Louis, MO), or heparitinase
(Sigma Chemical Co.) according to the instructions of the manufacturer in
the presence of protease inhibitors at various time intervals at 37
 
8
 
C. Sam-
ples incubated in parallel without enzyme served as control for proteolytic
contaminants. Digests were stopped by addition of SDS-PAGE sample
buffer, subjected to SDS-PAGE (7%), and visualized by fluorography (2-
5-diphenyloxazol [PPO] in DMSO).
 
Flow Cytometric Analysis
 
Immunoaffinity-purified proteins were coupled to red or green fluoresc-
ing microspheres with a diameter of 0.5 
 
m
 
m (Bioclean or Covaspheres;
Duke Scientific Corp., Palo Alto, CA) and incubated for binding as de-
tailed elsewhere (Kuhn et al., 1991; Brümmendorf et al., 1993; Morales
et al., 1993). In blocking experiments, protein-coated beads were preincu-
bated with Fab fragments of polyclonal antibodies to TN-C or -R. Analysis
of aggregated beads by flow cytometry using FACSCalibur
 
®
 
 and the Cell-
quest software package (Becton-Dickinson Immunocytometry Sys., Moun-
tain View, CA) for data acquisition has been outlined previously (Brüm-
mendorf et al., 1993).
 
Immunohistological Studies and In Vitro Bioassays
 
For the immunohistological localization of CALEB, TN-C, or TN-R, formal-
dehyde-fixed cryostat sections of embryonic tissue were incubated with
primary and Cy3-conjugated secondary antibodies (Dianova, Hamburg,
Germany) as described elsewhere (Rathjen et al., 1987
 
b
 
). Neurite exten-
sion on immobilized F11, NgCAM, laminin-1 (GIBCO BRL, Gaithers-
burg, MD), or vitronectin (Sigma Chemical Co.) in the presence of Fab
fragments of polyclonal antibodies or monoclonal antibodies to CALEB
was measured as detailed elsewhere (Chang et al., 1987; Brümmendorf et
al., 1993; Morales et al., 1993). To demonstrate specificity of the effects
observed with polyclonal antibodies to CALEB, 300-
 
m
 
l Fab fragments of
rabbit No. 1 at a concentration of 5 mg/ml were incubated with CALEB.
For this purpose, 8 
 
m
 
g of immunoaffinity-purified CALEB was immobi-
lized on nitrocellulose followed by blocking of residual binding sites on
the nitrocellulose by FCS. Fab fragments were incubated with immobi-
lized CALEB at 4
 
8
 
C overnight. Fab fragments were then applied to tectal
cell cultures at a concentration as indicated in Fig. 6. Alternatively, tectal
cells were grown in the presence of Fab fragments of rabbit No. 1 at a con-
centration of 800 
 
m
 
g/ml supplemented with 10 
 
m
 
g/ml of purified CALEB.
Fab fragments of polyclonal antibodies to the 3/11- or 12/36-antigen were
used at 1.6 mg/ml in tectal cultures.
 
Results
 
Screening for Novel Binding Components of
Axon-associated Proteins
 
To identify novel binding proteins, known axon-associated
proteins (F11, NgCAM, NrCAM, or NCAM) or ECM gly-
coproteins (TN-C, TN-R, or laminin-1) were immobilized
on ELISA plates (Fig. 1 
 
A
 
). After blocking and washing,
ELISA plates were incubated with detergent extracts of
embryonic retina tissue to allow putative binding proteins
to interact with the immobilized proteins. Plates were then
incubated with prescreened supernatants of hybridomas
generated against embryonic neural glycoprotein frac-
tions. (The prescreening procedure leads to a selection of
mAbs that stain predominantly developing fiber tracts and
the surface of extending axons.) The application of these
steps resulted in the identification of an mAb, termed 4/1,
that recognizes an antigen expressed on the surface of neu-
ral cells (see below). The antigen appeared to interact with
TN-C and -R, but not with other immobilized axon-associ-
ated proteins such as NrCAM, F11, or NCAM (Fig. 1 
 
B
 
 and
not shown). In comparison to TN-C or -R, weak binding was
also observed to NgCAM and laminin-1 on ELISA plates
(Fig. 1 
 
B
 
).
 
CALEB Is a Transmembrane Protein with an EGF-like 
Domain Related to Growth and Differentiation Factors
 
CALEB-encoding cDNAs were obtained by screening an
adult chicken eye cDNA library constructed in 
 
l
 
gt11 with
mAb 4/1. Additional overlapping clones were found in the
same library using the 1-kb insert of the initial cDNA
clone as a probe. The amino acid sequence deduced from
these overlapping cDNA clones predicts a polypeptide
with a molecular mass of 61 kD (Fig. 2 
 
A
 
). This calculated
mass differs from that of the carbohydrate-depleted poly-
peptide (110 kD) as analyzed by SDS-PAGE. Such differ-
ences between predicted and observed sizes have also
been reported for other proteins (Rauch et al., 1992 and
references therein) and might be due to low binding of
SDS by the highly negatively charged CALEB. Compari-
son of amino acid sequences obtained from the NH
 
2
 
 ter-
mini of the 200-, 140-, and 80-kD CALEB components
and from peptides generated from digests with trypsin and
proteinase Asp-N of immunopurified CALEB confirm the
identity of the sequence predicted by the cDNA clones
(Fig. 2 
 
A
 
). The NH
 
2
 
-terminal peptide sequences of the
140- and the 200-kD component of CALEB obtained by
Edman degradation are identical (starting at residue 19 in
Fig. 2 
 
A
 
), which is in agreement with the observation that
the 200-kD component is a proteoglycan form of the 140-
kD component (see below). The NH
 
2
 
 terminus of the 80-
kD component represents a sequence that starts at residue
260 (Fig. 2 
 
A
 
, 
 
dotted line
 
). It is currently unknown whether
the 80-kD polypeptide is generated by proteolytic process-
ing, alternative splicing of the pre-mRNA, or an alterna-
tive translation start. (The methionine at position 245
could serve as an initiator site.) 
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Analysis of the predicted amino acid sequence reveals
that the CALEB-polypeptide can be subdivided into sev-
eral segments (Fig. 2): The NH
 
2
 
-terminal region contains
several potential 
 
O
 
-glycosylation sites (Tomita et al., 1978;
Gooley et al., 1991) and two asparagines, which may be
modified by N-linked sugars (Kornfeld and Kornfeld, 1985).
This region contains SG or GS dipeptide sequences, two of
which (aa 73 and 74 and aa 115–117) fulfill the criteria for
potential attachment sites for chondroitin sulfate chains
(Bourdon et al., 1987; Zimmermann and Ruoslahti, 1989).
Additional potential sites for 
 
N
 
- and 
 
O
 
-glycosylation can
be found in the COOH-terminal direction of the NH
 
2
 
 ter-
minus of the 80-kD component of CALEB. This fits with
our results on deglycosylation experiments of purified
CALEB, which indicated that all molecular mass forms
contain N- and O-linked sugar chains (data not shown).
Residues 131–186 of the amino acid sequence of CALEB
compose a structural motif that, at first sight, resembles a
leucine zipper, a dimerization motif known from transcrip-
tion factors such as GCN4 (Landschulz et al., 1988). The
characteristic of a leucine zipper motif is the repetition of
a stretch of seven amino acids with a leucine in the first po-
sition and a hydrophobic amino acid in the fourth position.
CALEB contains an eightfold repetition of seven amino
acids with a leucine in every first position and a proline in
every fourth position (with one exception) (Fig. 2 
 
C
 
).
However, the presence of the prolines makes it unlikely
that this stretch of CALEB forms an 
 
a
 
-helical structure as
proposed for the leucine zipper motif (O`Shea et al., 1991).
Because of the regular spacing of leucines and prolines,
this structural element of CALEB was designated LP-motif.
Further in the COOH-terminal direction, there is a
stretch of sequence containing a cluster of acidic residues
(DDD . . . EED from residue 351 to 369). This structure
might be involved in cation binding and/or charge-based
interactions with other proteins. Human versican, bovine
brevican, and the 
 
b
 
-amyloid precursor protein contain a
similar stretch of acidic residues (Kang et al., 1987; Zim-
mermann and Ruoslahti, 1989; Yamada et al., 1994).
COOH-terminal of the acidic box, CALEB contains a
40–amino acid–long cysteine-rich segment. The number
(six) and the spacing of these cysteines in addition to the
conservation of two glycines and one arginine establishes
CALEB as a member of the EGF-family of differentiation
factors (Campbell and Bork, 1993; Massague and Pandi-
ella, 1993; Ben-Baruch and Yarden, 1994). The cysteine
configuration of CALEB is most similar to that found in
EGF, TGF-
 
a
 
, and neuregulin as analyzed with the bestfit
and clustal programs (Fig. 2 
 
B
 
). The small stalk between
the EGF domain and the following putative transmem-
brane segment does not contain any basic residues (L-R)
important for proteolytic cleavage as have been found for
all transmembrane forms of neuregulin. It is therefore
conceivable that CALEB exists only as a protease-resis-
tant form giving rise to a membrane associated EGF-like
domain. The proteolytic processing sequence of TGF-
 
a
 
,
however, also does not contain any basic amino acid resi-
dues (Massague and Pandiella, 1993).
Hydropathy analysis (Kyte and Doolittle, 1982) of the
predicted amino acid sequence revealed a hydrophobic
stretch of 24 amino acids in length (residues 479–502) fol-
lowed by two basic amino acids (KK) that might function
as a transmembrane domain (Sabatini et al., 1982) that dis-
sects the CALEB-polypeptide into a glycosylated extra-
cellular part and a short (49 aa long) cytoplasmic stretch
that contains several putative serine and threonine phos-
phorylation sites (Pearson and Kemp, 1991). No strong hy-
drophobic sequence that could function as a signal peptide
was detected at the NH
 
2
 
 terminus. This phenomenon is
also observed with other proteins, including some forms of
Figure 1. (A) Scheme of the screening procedure applied to iden-
tify novel binding proteins of known axon-associated glycoproteins.
(B) Identification of binding proteins to immobilized axon-asso-
ciated proteins. Immunoaffinity-purified proteins were immobi-
lized on ELISA plates (200 ng/well), followed by blocking by
BSA and washing. Plates were incubated with detergent extracts
of retinas from embryonic day 16, washed several times, and then
incubated with supernatants from preselected hybridomas. Bind-
ing as indicated by the optical density in ELISA plates is shown
for one monolonal antibody, termed 4/1. Bars on top of the col-
umns indicate SEM. 
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the neuregulins that also contain no classical signal pep-
tide (Wen et al., 1992). Despite the lack of a recognizable
strong hydrophobic sequence at the NH
 
2
 
 terminus, CALEB
under the control of the SV-40 promoter is expressed on
the surface of transfected COS7 cells as detected by cell
surface immunostaining using the mAb 4/1 (data not
shown). On the basis of the reactivity of mAb 4/1 to 
 
l
 
cDNA clones and to the molecular mass forms of CALEB,
its epitope can be allocated most likely between residues
260 to 442, indicating that the epitope is within the extra-
cellular region of CALEB.
Data bank searches indicate that CALEB is a novel pro-
tein. However, the EGF-like domain and the cytoplasmic
segment are highly related to neuroglycan-C (85% amino
acid identity), a recently described proteoglycan of the rat
nervous system of unknown function (Watanabe et al.,
1995). The residual two thirds of the amino acid sequences
of both proteins do not reveal any sequence homology,
and, furthermore, neuroglycan-C contains a stretch of ba-
sic residues instead of an acidic box and has no recogniz-
able LP-motif. This comparison suggests that CALEB and
neuroglycan-C might be products of different genes or are
different isoforms of the same gene generated by alterna-
tive pre-mRNA splicing.
Taken together, we have described a novel transmem-
brane protein composed of a highly glycosylated domain, a
leucine/proline-rich domain, an acidic box, and an EGF-
like domain dissected from the cytoplasmic stretch by a
transmembrane domain as indicated in Fig. 2 
 
D.
 
CALEB Is Composed of Several
Molecular Mass Components, Including a
Chondroitinsulfate-containing Form
 
mAb 4/1 was used to purify the antigen from detergent ex-
tracts of embryonic or adult retinas by immunoaffinity
chromatography (Fig. 3 
 
A
 
). The isolate from embryonic
retinas is composed of the following molecular mass com-
ponents: a band at 140 kD, and broad migrating bands at
80 and 200 kD (lane 
 
1
 
). The latter two components were
not or only weakly found in isolates from adult retinas,
while the 140 kD components appear as a doublet (140
and 130 kD) (lane 
 
2
 
). All these components observed in
silver-stained gels were recognized by mAb 4/1 in Western
blots,  indicating that they are immunologically related
 
Figure 2.
 
Amino acid sequence, schematic representation of
CALEB, and alignments. (
 
A
 
) The amino acid sequence of
CALEB deduced from six overlapping cDNA clones is shown us-
ing the single letter code. Numbering of amino acids is given at
the left. The open reading frame contains 551 amino acids. Dot-
ted lines correspond to the NH
 
2
 
-terminal sequences of the 200-,
140-, and 80-kD components of CALEB obtained by Edman deg-
radation. Sequences obtained from peptides of digests of trypsin
or Asp-N of CALEB are underlined and cysteine residues and
potential 
 
N
 
-glycosylation sites are marked by asterisks and dots,
respectively. The putative transmembrane domain is indicated by
double underlining. The NH
 
2
 
-terminal peptide sequences of the
200-, 140-, and the 80-kD component are APEWPPRXGXSGRA
(aa 19–32) and ARGRXDRTWLGAPEPI (aa 260–275), respec-
tively (X denotes an amino acid not to be defined by peptide se-
quencing). Sequences from proteolytic digests are DLPNPNLGL
(aa 158–166), DFYPTTSFYA (aa 339–348), VPPPPSPXEGTPM
(aa 388–400), XSSEXRSGYVR (aa 413–423), XNTQDYTXXK
(aa 457–466), and XRTPSEXHNDNFX (aa 520–532). The nucle-
otide sequence data are available from EMBL/GenBank/DDBJ
under accession number Y09264. (
 
B
 
) Alignment of the amino
acid sequences of the EGF-like domains and flanking COOH-
terminal residues of CALEB (chick) with neuroglycan-C (
 
NG-C
 
,
rat; Watanabe et al., 1995), transforming growth factor 
 
a
 
 (
 
TGF-
 
a
 
,
rat; Marquardt et al., 1984), epidermal growth factor (
 
EGF
 
, mouse;
Gray et al., 1983), or neuregulin-
 
a
 
 (
 
NDF
 
, rat; Wen et al., 1992).
Alignments obtained by the programs bestfit and clustal of the
HUSAR program package and by visual inspection start at the
most NH
 
2
 
-terminal cysteine residue of the EGF motifs. Dashes
indicate gaps that were introduced for maximal alignment. Iden-
tical residues corresponding to amino acids of CALEB are
printed in bold and marked by a cross. (
 
C
 
) The amino acid se-
quence of CALEB at residues 131 to 186 comprises a stretch of
primarily uncharged amino acids enriched in leucines and pro-
lines, designated LP-motif. A stretch of seven amino acids re-
peated eight times contains a leucine at position 1 and a proline
at position 4 (one exception). The periodicity of the leucine resi-
dues within the LP-motif resembles that of a leucine zipper; how-
ever, because of the existence of prolines, it is unlikely that this
element of CALEB forms an 
 
a
 
-helical structure as defined for
leucine zippers. (
 
D
 
) Schematic representation of the overall struc-
ture of CALEB. 
 
LP
 
, the leucine/proline-motif; 
 
acidic
 
, the acidic
box that is highly enriched in aspartic and glutamic acids; 
 
EGF
 
,
the EGF-like domain. A transmembrane segment (
 
TM
 
) sepa-
rates these segments from a short cytoplasmic stretch. 
The Journal of Cell Biology, Volume 136, 1997 900
 
(lanes 
 
3
 
 and 
 
4
 
). To characterize the CALEB components
further, CALEB was purified from cultivated retinal cells
that were biosynthetically labeled with [
 
35
 
S]sulfate. This
isolate is composed of identical molecular mass compo-
nents as that from embryonic retinal tissue (Fig. 3 
 
B
 
, lane
 
1
 
). Digestions with chondroitinase ABC, but not with hep-
aratinase or heparinase, completely eliminated the 200-kD
smear (Fig. 3 
 
B
 
, lane 
 
3
 
 and not shown). When the 200-kD
band was excised from the gel followed by chondroitinase
ABC digestion and then analyzed by SDS-PAGE, a 140-
kD band appeared (not shown). These results indicate that
the broad band at 200 kD contains chondroitinsulfate
chains attached to the 140-kD core polypeptide. Neuramini-
dase treatment results in a slightly increased electrophoretic
mobility of the 200- and 140-kD bands but not of the 80-
kD band (Fig. 3 
 
B
 
, lane 
 
2
 
). The finding that a substantial
portion of CALEB, the 140- and 80-kD forms, exists on
retinal cells without glycosaminoglycan chains attached
suggests that CALEB is a “part-time” proteoglycan, as it
has also been found for brevican (Yamada et al., 1994).
Analysis of Western blots of retinal tissues from differ-
ent embryonic ages revealed that the expression of the
CALEB components is regulated during embryonic devel-
opment of the retina (Fig. 4). The 140-kD component
appears very early in retinal development (at E7) and
reaches its maximum at E20. In comparison to the 140-kD
component, the 130-kD band appears delayed in its ex-
pression but also reaches its maximum at E20. In contrast,
the lower molecular mass component at 80 kD reveals its
strongest expression at E14/E15 and then gradually de-
clines and is not detectable in adult stages (Fig. 4 and not
shown).
 
CALEB Binds to TN-C and -R
 
To further substantiate the finding of the mutual affinity
of CALEB and TN-C or CALEB and TN-R, we examined
the binding of protein-coated microspheres, an assay pre-
viously found suitable and reliable to analyze protein–pro-
tein interactions. Affinity-purified CALEB and other
axon-associated proteins were coupled to fluorescent mi-
crospheres of red or green fluorochromes. Mixtures of
beads were then incubated for 1 h at room temperature
followed by an analysis with the flow cytometer. In dual
combinations, only the TN-R– and TN-C–conjugated beads
were found to be associated with CALEB beads (Fig. 5, 
 
A
 
and 
 
B
 
). Specificity of these heterophilic CALEB-TN-R or
-C binding could be demonstrated by incubation of differ-
ent combinations of microspheres coated with other ax-
onal glycoproteins. CALEB was found not to bind to Ng-
CAM, NrCAM, NCAM, F11, or laminin-1 (Fig. 5, 
 
C–E
 
 and
not shown). The binding between CALEB and TN-R or
between CALEB and TN-C could be blocked by Fab frag-
ments of polyclonal antibodies to TN-R or -C, respectively
(Fig. 5 
 
F
 
 and not shown). The weak interactions between
NgCAM and CALEB or between laminin-1 and CALEB
observed on ELISA plates only could not be confirmed
with these methods. It is therefore conceivable that the
NgCAM-CALEB binding is an artifact since NgCAM im-
mobilized on ELISA plates binds nonspecifically to many
other proteins (our unpublished observations).
To analyze whether TN-C or -R copurifies with CALEB,
affinity isolates of CALEB were subjected to Western
blotting using mAbs to TN-C or -R. Isolates of CALEB
from embryonic but not from adult retinas, which were not
washed with high salt, were found to contain TN-C but not
TN-R (Fig. 3 
 
C, lanes 1 and 2, respectively). The coisolat-
ing TN-C could be eluted from the column by 1.2 M NaCl
(Fig. 3 D, lanes 1–3), suggesting a charge-based interaction
between CALEB and TN-C. One reason for the coisola-
tion of TN-C on anti-CALEB affinity columns in contrast
to TN-R might be that TN-C expression dominates over
the TN-R expression within the developing retina (see
also below). In summary, the currently available binding
data support the notion that CALEB is a high-affinity
TN-C– or TN-R–binding protein, while the interactions
between CALEB and NgCAM or laminin-1 need further
investigations.
Figure 3. CALEB components in
neural tissues. (A) Polypeptides
isolated by immunoaffinity chro-
matography using mAb 4/1 from
embryonic (lane 1) or adult reti-
nas (lane 2) analyzed by 7% SDS-
PAGE followed by silver staining.
Immunotransfer analysis of
CALEB isolates from embryonic
(lane  3) or adult retinas (lane 4) us-
ing mAb 4/1. (B) CALEB com-
ponents after biosynthetical la-
beling with [35S]sulfate of retinal
monolayer cultures in vitro (lane
1) followed by digestion with
neuraminidase (lane 2) or chon-
droitinase ABC (lane 3). Bands were visualized by fluorography. (C) TN-C copurifies with CALEB from embryonic retinas. CALEB
was isolated from embryonic retinas by immunoaffinity chromatography by omitting the high-salt washing step, subjected to SDS-
PAGE (7%), and analyzed in immunotransfers using mAb 68 directed to TN-C (lane 1) or mAb 23-13 to TN-R (lane 2). (D) The high-
salt fraction of anti-CALEB columns consists of TN-C. The CALEB immunoaffinity column loaded with detergent extracts of embry-
onic retinas followed by washing with solubilization buffer was preeluted with three column volumes of 1.2 M NaCl in PBS. The high-
salt fraction was analyzed in SDS-PAGE followed by silver staining (lane 1) or analyzed in immunotransfers using mAb 68 to TN-C (lane
2) or mAb 23-13 to TN-R (lane 3). Molecular mass markers are indicated at the left of each panel.Schumacher et al. CALEB, a Differentiation Factor of the EGF Family 901
Antibodies to CALEB Interfere with Neurite Formation 
on Different Substrates In Vitro
To study the biological function of CALEB, neurite out-
growth assays in a permissive environment provided by
specific IgSF members, by laminin-1 or vitronectin in the
presence of antibodies to CALEB, were performed. (The
ECM glycoproteins TN-R and -C are nonpermissive for
neurite extension for most neurons.) While the density of
E6 tectal cells attached to the substratum was increased in
the presence of Fab fragments of polyclonal antibodies to
CALEB (data not shown), neurite length on either an F11,
NgCAM, laminin-1, or vitronectin substratum was dra-
matically diminished, suggesting that the effects of anti-
CALEB antibodies are substrate independent (Fig. 6, A–C,
and not shown). We used antisera from four different rab-
bits that appear functionally identical; however, the degree
of reduction in neurite length varied and was dependent on
the Fab concentration applied. (The tested concentration
range was 300–1,000 mg/ml.) The effects on F11- or vitro-
nectin-mediated neurite extension appeared generally
stronger than on NgCAM- or laminin-1–dependent exten-
sion. To demonstrate specificity, tectal cells were grown in
the presence of Fab fragments that have been preincu-
bated with immobilized CALEB (Fig. 6 D) or in the pres-
ence of both Fab fragments and purified CALEB. In both
cases, the activity of the Fab fragments was completely
neutralized, indicating that the effects observed are due to
antibodies recognizing CALEB. Furthermore, Fab frag-
ments of polyclonal antibodies to two recently character-
ized neuronal cell surface antigens, the 12/36 or the 3/11-
antigen, did not affect neurite extension of tectal cells even
when used at a much higher concentration, indicating that
Fab preparations generated under identical conditions
have no general toxic effect on tectal cells and that binding
of Fabs to axonal surface alone does not cause a reduction
of neurite length. mAb 4/1 was not found to affect neurite
formation on all substrates tested (Fig. 6, A and B). Our
observations therefore suggest that Fab fragments of poly-
clonal antibodies to CALEB specifically impair the ability
of tectal neurons to form neurites in a permissive environ-
ment and might identify CALEB as a competence factor
for neurite extension.
CALEB Is Associated with Glial and Neuronal Surfaces 
In Vivo and In Vitro
In the embryonic retina, CALEB immunoreactivity coin-
cides with the formation of the inner plexiform layer (IPL)
in the central retina at E7/E8 (Fig. 7 a). At later stages, the
intensity of staining gradually increases in the IPL, which
is then uniformly labeled (Fig. 7 d). In addition, homoge-
neous CALEB staining was observed in the outer plexi-
form layer (OPL) and in the optic fiber layer (OFL). At E8,
a prominent labeling of Müller cell processes transversing
the ganglion cell layer and the optic fiber layer was de-
tected (Fig. 7 b). In the GCL and the OFL, the processes
of these glial cells are thicker and ramify, and the pattern
of staining reflects this (Prada et al., 1989, 1991). In the in-
ner nuclear layer, the staining is faint. At E8, the immuno-
staining pattern of TN-C is similar to that of CALEB dom-
inating in the developing IPL and on the Müller cell
processes (Fig. 7, c and f). TN-R immunoreactivity has a
slightly different pattern of localization than CALEB. It is
present in the IPL and OPL, but weak in the OFL (Fig. 7 e).
The staining pattern in the developing retina indicates
Figure 4. The expression of CALEB components in the retina is
developmentally regulated. Retinas of different embryonic ages
were solubilized, and equal amounts of proteins were resolved by
SDS-PAGE (7%) followed by immunotransfer analysis using
mAb 4/1 to CALEB. E8 (lane 1), E10 (lane 2), E12 (lane 3), E14
(lane 4), E16 (lane 5), E18 (lane 6), and E20 (lane 7). Molecular
mass markers are indicated at the left of the panel.
Figure 5. Binding of CALEB to TN-R or to TN-C analyzed by
flow cytometry. CALEB, TN-R, or TN-C were coupled to fluo-
rescent microspheres, mixed, and incubated for 1 h at a 1:1 ratio.
Aliquots were analyzed by flow cytometry. Two parametric mea-
surements are documented as contour plots using a logarithmic
scale for both axes. The fluorescence intensity corresponds to the
size of aggregates. Only beads coated with TN-R (A) or TN-C
(B), but not F11 (C), NgCAM (D), or NrCAM (E) formed large
mixed aggregates with CALEB. The binding between CALEB
and TN-C could be completely blocked by Fab fragments of poly-
clonal antibodies to TN-C (F).The Journal of Cell Biology, Volume 136, 1997 902
an association with glial surfaces and suggests an associa-
tion with neuronal surfaces in the plexiform layers. A clear
association of CALEB immunoreactivity with neuronal
surfaces, however, was observed in the developing cere-
bellum where antibodies to CALEB stain primarily the
Purkinje cells and their dendritic trees (Fig. 7 g), and at
more advanced stages, CALEB expression is dominant
throughout the molecular layer (not shown). Weaker la-
beling is observed in the developing internal granular
layer, and very faint staining is seen on structures trans-
versing the external granular layer, probably Bergmann
glia cells. In comparison, TN-C shows a more widespread
and uniform distribution in the developing cerebellum
(Fig. 7 h). Taken together, in vivo CALEB immunoreac-
tivity is associated with astroglial and neuronal surfaces
in different parts of the embryonic brain. Furthermore,
Western blot analysis and protein purifications indicate
that the 140-kD form of CALEB is also found in the adult
retina and brain (Fig. 3 A, lane 4 and not shown). CALEB
labeling was not detected outside the nervous system. In in
vitro cultures, CALEB was associated with the surface of
processes of retinal and tectal neurons, of astrocytes, and
of oligodendrocytes of the optic nerve (data not shown).
Discussion
By combining the sensitivity of binding detection in ELI-
SAs with immunological screens, we were able to establish
CALEB as a novel transmembrane protein of neurons and
glial cells of the developing nervous system that interacts
with the ECM glycoproteins TN-R and -C. The most re-
markable structural motif identified in this protein is an
EGF-like domain. Alignment analysis showed that the
EGF-like domain is most similar to EGF, to that found in
TGF-a or in neuregulin, and fits with the criteria used to
group the latter three and some other proteins together
into the family of transmembrane growth and differentia-
tion factors. One subgroup of this family comprises the dif-
ferent neuregulin isoforms, while the other subfamily is
composed of EGF, TGF-a, HBEGF, amphiregulin, and
betacellulin (Massague and Pandiella, 1993; Peles and
Yarden,  1993; Carraway and Burden, 1995). All members
of the latter subgroup bind to the receptor tyrosine kinase
ErbB1, while the EGF-like domains of the neuregulins are
ligands of ErbB3 and ErbB4. It is assumed that the differ-
ent distance between cysteine 3 and 4 in the EGF-like do-
main of these two subgroups causes a different loop length
Figure 6. Distribution of
neurite lengths of tectal cells
in the presence and absence
of antibodies to CALEB.
Culture dishes were coated
with immunoaffinity puri-
fied F11 (A and D), NgCAM
(B,  E,  and  F), or laminin-1
(C) and blocked with culture
medium containing FCS.
Dissociated tectal cells were
cultivated on NgCAM or
laminin-1 (LN) for 22 h and
on F11 for 30 h in culture me-
dium containing FCS. Con-
trol cultures were grown
without antibodies and test
cultures in the presence of
Fab fragments of anti-
CALEB antibodies from
four different rabbits (Nos. 1,
4, 6, or 7) using different con-
centrations as indicated in
each panel (300–1,000 mg/
ml). Purified mAb 4/1 was
used at 10 mg/ml. In D, tectal
cultures were grown on F11
without antibodies, in the
presence of Fab fragments
of antibodies to CALEB, or
in the presence of Fab frag-
ments preincubated with im-
munoaffinity-purified CALEB
immobilized on nitrocellu-
lose (neutralized; for details see Materials and Methods). In E, tectal cells were grown on NgCAM in the absence of Fab fragments or
in the presence of both Fab fragments (800 mg/ml) and immunopurified CALEB (10 mg/ml). Cultures were fixed, stained, and ana-
lyzed using an inverted microscope and an image analysis system. The percentage of neurons (vertical axis) with neurites longer than 20
mm (horizontal axis) is plotted as introduced by Chang et al. (1987). For each experimental condition, 90–100 neurites were measured.
The broken lines in A, B, C, and D indicate that there are no neurons with neurites at the indicated Fab concentration. (The length dis-
tributions have been analyzed using the Mann-Whitney U-test and relevant p-values are given: in B, control versus Fab at 330 mg/ml
P , 0.0001; in C, control versus Fab at 400 mg/ml P , 0.0001; in E, control versus Fab plus CALEB P , 0.01.)Schumacher et al. CALEB, a Differentiation Factor of the EGF Family 903
that might contribute to binding specificity to a particular
receptor (Peles and Yarden, 1993). The interval between
cysteine 3 and 4 in the EGF-like domain of CALEB is dif-
ferent from that in the neuregulins but similar to that in
EGF and TGF-a. In contrast, the spacing between cys-
teine 5 and 6 is longer in CALEB than in any other mem-
ber of these EGF-like domains. If one assumes a ligand
function for CALEB, it is therefore likely that CALEB in-
teracts with a receptor distinct from ErbB1 and ErbB3/4.
All known members of the family of growth and differ-
entiation factors can generate a diffusible EGF-like domain
from the transmembrane precursor by proteolytic process-
ing with cleavages on both sides of the EGF-like domain
(Massague and Pandiella, 1993). TGF-a is able to activate
its receptor both as transmembrane and as released form
(Brachmann et al., 1989). TGF-a does not contain basic
amino acid residues at the cleavage sites surrounding the
EGF-like domain as have been found for neuregulin and
EGF. Instead, there are small apolar amino acids. The
short stalk in the sequence of CALEB between the EGF-
like domain and the transmembrane segment also does
not contain basic residues but does contain the tripeptide
AIV (aa 472–474), which resembles the cleavage site se-
quence found in TGF-a (AVV). Currently, we have no
biochemical data indicating that the EGF-like domain of
CALEB can be released by proteolytic processing. Never-
theless, we are able to isolate different molecular mass
forms of CALEB, and we demonstrate that the 80-kD
component of CALEB is specifically regulated during de-
velopment. For example, in the retina the 80-kD form is
found predominantly during stages when synaptic connec-
tions are being established (Hughes and LaVelle, 1974;
Hering and Kröger, 1996) and is downregulated in the
adult. Immunohistochemical analysis reveals the presence
Figure 7. Localization of CALEB in sections of the developing retina and cerebellum. Cryostat sections were stained indirectly by mAb
4/1 directed to CALEB (a, b, d, and g), by mAb M1 to TN-C (c, f, and h) or mAb 23-13 to TN-R (e). Staining was visualized by fluores-
cence. Retinas were from 8-d-old (a, b, c, and e) or from 12-d-old chicken embryos (d and f). Cerebella were from 18-d-old chicken em-
bryos (g and h). b shows the distribution of CALEB in the OFL at a higher magnification as shown in a. EGL, external granular layer;
IGL, internal granular layer; PC, Purkinje cells.The Journal of Cell Biology, Volume 136, 1997 904
of CALEB in the synapse-rich layers IPL and OPL of the
retina. In this context, it is interesting that one isoform of
neuregulin, termed ARIA, was identified as inducing ac-
tivity of acetycholine receptor synthesis (Falls et al., 1993;
Chu et al., 1995; Jo et al., 1995). Loeb and Fischbach
(1995) presented data showing that ARIA binds to extra-
cellular matrix molecules, and they postulated a model
that suggests that the access of ARIA to the ErbB3/4 re-
ceptors on the postsynaptic membrane is regulated by pro-
teolytical release from the extracellular matrix. We have
demonstrated an interaction between CALEB and two
large ECM molecules, TN-C and -R. We further showed
by immunohistochemical analysis that all three molecules
(CALEB, TN-C, and TN-R) have an overlapping distribu-
tion in synapse-rich areas in the retina. In analogy to the
results presented by Loeb and Fischbach, it is possible that
because of their interaction with CALEB, TN-C and -R
regulate the accessibility of CALEB to its corresponding
receptor. It is currently not possible to decide whether the
80-kD component is generated by proteolytic processing
of the 140-kD polypeptide, by splicing events or by the use
of an alternative translation start site. However, the com-
bined data indicate that the 80-kD component is not a dif-
fusible form of CALEB and suggest that both major forms
of CALEB, the 140- and 80-kD components, may be able
to exert their biological action via a juxtacrine mechanism
like TGF-a.
In addition to this EGF motif, CALEB contains the LP-
motif, a leucine-rich sequence resembling a leucine zipper,
which might enable CALEB to interact with other pro-
teins. Leucine zipper structures are known from many
transcription factors and allow them to homo- or hetero-
dimerize. Whether the LP-motif within the sequence of
CALEB is able to fold into a regularly secondary structure
remains to be determined. Connectin, a cell adhesion mol-
ecule of Drosophila with a repulsive function during growth
cone guidance and synapse formation, also possesses
leucine-rich repeats (Nose et al., 1992). The spacing of the
leucines, however, is different from the LP-motif of
CALEB, and there are no regularly spaced prolines within
these repeats of connectin. At present nothing is known
about the function of these repeats in this Drosophila pro-
tein. In addition to several potential glycosylation sites,
the CALEB sequence contains two potential tyrosine sul-
fation sites (aa 289–294 and 327–331; Huttner, 1987), and
there are biochemical data that indicate tyrosine sulfate in
the protein core of CALEB (Roth, S., and F.G. Rathjen,
unpublished data). One very interesting possible function
of tyrosine sulfate was elucidated by Sako et al. (1995) and
Pouyani and Seed (1995), who demonstrated that a sul-
fated peptide segment of PSGL-1 is neccessary to build up
the high-affinity binding site for P-selectin.
Neuroglycan-C, a recently described proteoglycan of the
rat nervous system, has an EGF-like and a cytoplasmic do-
main that is 85% identical in the amino acid sequence with
the corresponding region of CALEB (Watanabe et al.,
1995). The remaining two thirds of both sequences are
completely unrelated. In particular, in neuroglycan-C there
is no leucine/proline-rich segment (LP-motif), and in con-
trast to CALEB, it contains a highly basic stretch of se-
quence. Neuroglycan-C expresses a classical signal peptide
that is not seen in CALEB. CALEB and neuroglycan-C
might therefore be products of different genes or different
isoforms of equivalent genes in two different species. It
will be interesting to see in the future whether there exists
a family of related genes or multiple isoforms as it has
been described for the neuregulins. Interestingly, we found
a short piece of EST sequence (human) in data banks (These
sequence data are available from GenBank/EMBL/DDB
under accession number h05182.emnew.) that, when trans-
lated, yields a peptide that is highly related to the EGF-
like domain of CALEB. This might indicate that the type
of EGF domain present in CALEB is highly conserved
during evolution.
In addition to their roles as glial growth, maturation,
and survival factor, the neuregulins are implicated in a va-
riety of biological processes during the development of the
nervous system (Marchionni et al., 1993; Pinkas-Kramar-
ski et al., 1994; Dong et al., 1995). Gene targeting experi-
ments have revealed that the neuregulins are essential for
the neurogenic lineage of the cranial neural crest (Meyer
and Birchmeier, 1995). Furthermore, Bermingham-McDon-
ogh et al. (1996) presented evidence that the neuregulins
stimulate survival and neurite extension of retinal cells in
culture in a dose-dependent manner. These multiple re-
sponses might be due to different isoforms of the neuregu-
lins or different combinations of receptors. We were inter-
ested in whether CALEB might be implicated in the
process of neurite formation and have therefore tested if
antibodies to CALEB disturb neurite formation of tectal
cells grown on NgCAM or F11, two axonal members of
the IgSF; or laminin-1 or vitronectin, two ECM glycopro-
teins. Fab fragments of four different antisera were able to
suppress neurite formation, and this effect is independent
of the substrate used. The effect could be neutralized by
preincubation of the Fab fragments with CALEB, exclud-
ing the possibility of nonspecific or general toxic side ef-
fects of the Fabs. The impairment of neurite formation
caused by antibodies to CALEB could be the result of at
least four different mechanisms: (a) CALEB might be a
general axonal receptor for the substrates tested. No direct
interaction between CALEB and the substrates used was
observed that could be supported by different indepen-
dent binding assays. Therefore, it is unlikely that CALEB
serves as a receptor protein on the axonal surface for these
substrates. Furthermore, previous experiments have shown
that neurite outgrowth on F11 is mediated by NrCAM
(Morales et al., 1993), on NgCAM by an homophilic inter-
action (Lemmon et al., 1989), and on laminin-1 or on vitro-
nectin by integrins (Venstrom and Reichardt, 1993). (b)
The transmembrane form of CALEB itself might be a
signaling receptor, and binding of antibodies to CALEB
mimicks binding of an unknown ligand, resulting in intra-
cellular changes that culminate in the blockade of neurite
formation. By analogy to TGF-a and neuregulin, however,
the probability is low—although not excluded—that CALEB
itself is a signaling receptor protein. (c) Antibodies to
CALEB might interfere with the proteolytical processing
of CALEB, preventing the release of a CALEB form ac-
tive in a paracrine or autocrine manner. (d) Antibodies
to CALEB might directly block the EGF-like domain of
CALEB. The latter two cases assume that the EGF-like
domain contains a receptor recognition site that activates
an unknown tectal receptor protein to transmit a signal toSchumacher et al. CALEB, a Differentiation Factor of the EGF Family 905
tectal cells. This receptor would then generate an intracel-
lular differentiation signal that might make tectal neurons
competent for neurite formation in an appropriate envi-
ronment, as provided by the axonal IgSF members or
ECM proteins. If this interpretation can be supported by
future studies, it is likely that CALEB is of interest in stud-
ies of neurodegenerative diseases and in the regeneration
of axons after injury. The downregulation of specific mo-
lecular mass forms of CALEB during development of the
central nervous system might be in line with such assump-
tions.
In summary, this study has established CALEB as a
member of the EGF differentiation factors that is impli-
cated in neurite formation in vitro in a permissive environ-
ment. Further understanding of the function of CALEB
will require the identification of its cellular receptor(s) and
of biologically active forms that are released from the cell
surface.
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